Squarepoint
INSP icon

Squarepoint’s Inspire Medical Systems INSP Stock Holding History

Squarepoint’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
24,259
-42,555
-64% -$2.02M ﹤0.01% 2842
2026
Q1 		$3.45M Buy
66,814
+59,992
+879% +$4.2M ﹤0.01% 1778
2025
Q4 		$629K Sell
6,822
-16,322
-71% -$1.56M ﹤0.01% 3017
2025
Q3 		$1.72M Buy
+23,144
New +$2.34M ﹤0.01% 2227
2025
Q2 		– Sell
-2,835
Closed -$452K – 4755
2025
Q1 		$452K Buy
2,835
+358
+14% +$64.8K ﹤0.01% 3402
2024
Q4 		$459K Buy
+2,477
New +$481K ﹤0.01% 3798
2024
Q3 		– Sell
-26,294
Closed -$4.57M – 4378
2024
Q2 		$3.52M Buy
+26,294
New +$4.98M 0.01% 1624
2024
Q1 		– Sell
-26,539
Closed -$5.2M – 4280
2023
Q4 		$5.4M Sell
26,539
-29,573
-53% -$4.79M 0.01% 1342
2023
Q3 		$11.1M Buy
+56,112
New +$14.2M 0.03% 752
2023
Q2 		– Sell
-35,819
Closed -$10.2M – 3777
2023
Q1 		$8.38M Buy
35,819
+2,401
+7% +$607K 0.03% 639
2022
Q4 		$8.42M Sell
33,418
-10,379
-24% -$2.21M 0.03% 579
2022
Q3 		$7.77M Buy
43,797
+24,894
+132% +$5M 0.04% 539
2022
Q2 		$3.45M Buy
18,903
+15,857
+521% +$3.16M 0.02% 869
2022
Q1 		$782K Buy
3,046
+2,075
+214% +$474K ﹤0.01% 1734
2021
Q4 		$223K Sell
971
-1,166
-55% -$285K ﹤0.01% 2631
2021
Q3 		$498K Sell
2,137
-14,302
-87% -$2.98M ﹤0.01% 1964
2021
Q2 		$3.18M Buy
16,439
+11,777
+253% +$2.34M 0.01% 938
2021
Q1 		$965K Sell
4,662
-1,422
-23% -$302K 0.01% 1529
2020
Q4 		$1.14M Buy
+6,084
New +$995K 0.01% 1237
2020
Q2 		– Sell
-6,969
Closed -$420K – 2360
2020
Q1 		$420K Sell
6,969
-6,919
-50% -$512K 0.01% 1131
2019
Q4 		$1.03M Sell
13,888
-3,897
-22% -$250K 0.01% 1316
2019
Q3 		$1.08M Sell
17,785
-5,515
-24% -$363K 0.01% 1177
2019
Q2 		$1.41M Buy
23,300
+18,475
+383% +$996K 0.01% 1048
2019
Q1 		$274K Buy
+4,825
New +$261K ﹤0.01% 1814

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Squarepoint's INSP Position: Q2 2026 in Review

Squarepoint reduced its Inspire Medical Systems (INSP) stake by 64% in Q2 2026, selling an estimated $2.02M and leaving 24,259 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2842.

Squarepoint first reported a position in INSP in Q1 2019 and has held it in 24 quarters since. The position peaked at $11.1M in Q3 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Squarepoint held 24,259 shares of Inspire Medical Systems worth $1.08M as of Q2 2026.
  • Squarepoint sold 42,555 Inspire Medical Systems shares in Q2 2026, an estimated $2.02M.
  • Inspire Medical Systems made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2842 holding.
  • Squarepoint first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 24 quarters since.
  • Squarepoint's Inspire Medical Systems position peaked at $11.1M in Q3 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.